VEPESID Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Vepesid, and what generic alternatives are available?

Vepesid is a drug marketed by Strides Pharma and Corden Pharma and is included in two NDAs.

The generic ingredient in VEPESID is etoposide. There are eleven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the etoposide profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Vepesid

A generic version of VEPESID was approved as etoposide by HIKMA on July 17^th, 1995.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for VEPESID?
What are the global sales for VEPESID?
What is Average Wholesale Price for VEPESID?

Summary for VEPESID

US Patents:	0
Applicants:	2
NDAs:	2
Raw Ingredient (Bulk) Api Vendors:	90
Clinical Trials:	230
Patent Applications:	2,711
DailyMed Link:	VEPESID at DailyMed

Drug patent expirations by year for VEPESID

Recent Clinical Trials for VEPESID

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
RenJi Hospital	Phase 2
Incyte Corporation	Phase 2
Joseph Tuscano	Phase 2

See all VEPESID clinical trials

US Patents and Regulatory Information for VEPESID

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Strides Pharma	VEPESID	etoposide	CAPSULE;ORAL	019557-001	Dec 30, 1986		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Strides Pharma	VEPESID	etoposide	CAPSULE;ORAL	019557-002	Dec 30, 1986		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Corden Pharma	VEPESID	etoposide	INJECTABLE;INJECTION	018768-001	Nov 10, 1983		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for VEPESID

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Strides Pharma	VEPESID	etoposide	CAPSULE;ORAL	019557-001	Dec 30, 1986	⤷ Sign Up	⤷ Sign Up
Corden Pharma	VEPESID	etoposide	INJECTABLE;INJECTION	018768-001	Nov 10, 1983	⤷ Sign Up	⤷ Sign Up
Strides Pharma	VEPESID	etoposide	CAPSULE;ORAL	019557-002	Dec 30, 1986	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for VEPESID

See the table below for patents covering VEPESID around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
France	6307		⤷ Sign Up
France	1502813	Nouveau dérivé de la podophyllotoxine et sa préparation	⤷ Sign Up
Switzerland	472403	Verfahren zur Herstellung eines 4'-Demethyl-epipodophyllotoxins	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for VEPESID

Recent Clinical Trials for VEPESID

Make Better Decisions: Try a trial or see plans & pricing